Skip to Content

TEVA 5907 TEVA 5907 (Mesalamine Delayed-Release 400 mg)

Pill with imprint TEVA 5907 TEVA 5907 is Clear, Capsule-shape and has been identified as Mesalamine Delayed-Release 400 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis, maintenance; ulcerative proctitis; ulcerative colitis and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 5907 TEVA 5907

Mesalamine Delayed-Release

Imprint
TEVA 5907 TEVA 5907
Strength
400 mg
Color
Clear
Shape
Capsule-shape
Availability
Prescription only
Drug Class
5-aminosalicylates
Pregnancy Category
B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-5907

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.